Alström Syndrome
📧 Sign up to get email alerts when something new happens for Alström Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity [Phase 3]
Phase 3 trial of setmelanotide (MC4R agonist) in Bardet-Biedl and Alström syndromes with obesity has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome [Phase 2, Phase 3]
Open-label rollover study of PBI 4050 in Alström syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome [Phase 2]
Phase 2 trial update on safety, tolerability, and biomarker effects of PBI-4050 in subjects with Alström Syndrome, a condition involving inf…